© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
How Do We Re-Design the Treatment?
A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease
SpR Public Health Medicine, NHS Greater Glasgow & Clyde
Correspondence to: Dr Joy Tomlinson, SpR Public Health Medicine, NHS Greater Glasgow & Clyde. Email: joy.tomlinson@ggc.scot.nhs.uk
| The first 150 words of the full text of this article appear below. |
| Introduction |
|---|
Early chronic kidney disease (CKD) is now known to be a relatively common problem. Prevalence studies worldwide have estimated that between 6% and 11% of the population has CKD [1]. One recent estimate carried out in the UK found that 4.9% of the general practice population studied had an estimated glomerular filtration rate equivalent to stages 3–5 CKD [2].
There is now reliable research evidence to support a variety of clinical interventions that will benefit patients with CKD [3]. However, very little evidence is available in the literature to recommend the most effective way of delivering healthcare for patients with early CKD [3]. These patients comprise a complex group and unfortunately they often have significant comorbid conditions [4,5]. Specialist services would be overwhelmed if they attempted to manage all patients with early CKD [5]. It is
| Guidelines |
|---|
| Evidence from the literature |
|---|
Secondary care studies
Primary care studies
| Models of care |
|---|
| Quality and outcomes framework |
|---|
| Cost |
|---|
| Information strategy |
|---|
| Conclusion |
|---|